The Institute of Cancer Research (ICR)

Validation of a novel risk score to predict early and late recurrence in solitary fibrous tumour (2022) Georgiesh T, Aggerholm-Pedersen N, Schoffski P, Zhang Y, Napolitano A, Bovee JVMG, Hjelle A, et al. Journal article Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study (2022) Dixon-Suen SC, Lewis SJ, Martin RM, English DR, Boyle T, Giles GG, Michailidou K, et al. Journal article Perspectives on the Risk-Stratified Treatment of Multiple Myeloma (2022) Davies FE, Pawlyn C, Usmani SZ, San-Miguel JF, Einsele H, Boyle EM, Corre J, et al. Journal article Ovarian function in young patients (pts) treated with postneoadjuvant palbociclib (PAL) and endocrine therapy (ET) for hormone receptor (HR)-positive, HER2-negative early breast cancer (BC): Explorative analysis in Penelope-B (2022) Furlanetto J, Marme F, Thode C, Nekljudova V, Liu Y, Jimenez MM, Reimer T, et al. Conference contribution Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci (2022) Chen H, Fan S, Stone J, Thompson DJ, Douglas J, Li S, Scott C, et al. Journal article Rare germline copy number variants (CNVs) and breast cancer risk (2022) Dennis J, Tyrer JP, Walker LC, Michailidou K, Dorling L, Bolla MK, Wang Q, et al. Journal article Common variants in breast cancer risk loci predispose to distinct tumor subtypes (2022) Ahearn TU, Zhang H, Michailidou K, Milne RL, Bolla MK, Dennis J, Dunning AM, et al. Journal article COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network (2021) Ludwig H, Sonneveld P, Facon T, San-Miguel J, Avet-Loiseau H, Mohty M, Mateos MV, et al. Journal article, Review article Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage (2021) Fernandez De Larrea C, Kyle R, Rosinol L, Paiva B, Engelhardt M, Usmani S, Caers J, et al. Journal article MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma (2021) Kang EY, Millstein J, Popovic G, Meagher NS, Bolithon A, Talhouk A, Chiu DS, et al. Journal article